Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Adams, S. Appleton, D. Wilson, R. Ruffin (Woodville, SA, Australia). The risk of cardiovascular disease associated with asthma may be mediated by short-acting β₂-agonists. Eur Respir J 2008; 32: Suppl. 52, 1192

Member's Comments

No comment yet.

Related content which might interest you: Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Chronic bronchitis, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases. Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017 Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 45s Year: 2005 In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017 Neutrophils and the increased risk of cardiovascular events in severe COPD Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 The impact of airway infection on cardiovascular risk during COPD exacerbations Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD Source: Eur Respir J 2010; 35: 1003-1021 Year: 2010 The association between COPD and cardiovascular disorders Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Acute exacerbation in COPD and relationship between cardiovascular risk and functional profile Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Budesonide is not associated with increased risk of pneumonia in COPD patients Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009